FDA Approves Weekly Contraceptive Patch

“The FDA recently approved Twirla, a weekly contraceptive patch containing 30 mcg levonorgestrel and 120 mcg ethinyl estradiol, for women of reproductive age with a BMI less than 30 kg/m2 and for whom a combined hormonal contraceptive is appropriate.” The patch “contains a boxed warning regarding the risk for CV events in women aged 35 years and older who smoke and have a BMI greater than 30 kg/m2,” and should be available to wholesalers at the end of the year, according to the manufacturer. https://www.healio.com/primary-care/womens-health/news/online/%7Bbca67a23-3944-4e51-b3b1-cafb1fed88f0%7D/fda-approves-twirla-contraceptive-patch